ID   ARI1A_MOUSE             Reviewed;        2283 AA.
AC   A2BH40; Q640Q1; Q925Q1;
DT   09-FEB-2010, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   07-APR-2021, entry version 129.
DE   RecName: Full=AT-rich interactive domain-containing protein 1A;
DE            Short=ARID domain-containing protein 1A;
DE   AltName: Full=BRG1-associated factor 250;
DE            Short=BAF250;
DE   AltName: Full=BRG1-associated factor 250a;
DE            Short=BAF250A;
DE   AltName: Full=Osa homolog 1;
DE   AltName: Full=SWI-like protein;
DE   AltName: Full=SWI/SNF complex protein p270;
DE   AltName: Full=SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;
GN   Name=Arid1a; Synonyms=Baf250, Baf250a, Osa1, Smarcf1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING (ISOFORM 3),
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11318604; DOI=10.1006/geno.2001.6477;
RA   Kozmik Z., Machon O., Kralova J., Kreslova J., Paces J., Vlcek C.;
RT   "Characterization of mammalian orthologues of the Drosophila osa gene: cDNA
RT   cloning, expression, chromosomal localization, and direct physical
RT   interaction with Brahma chromatin-remodeling complex.";
RL   Genomics 73:140-148(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION OF THE NBAF AND NPBAF COMPLEXES, IDENTIFICATION BY MASS
RP   SPECTROMETRY, IDENTIFICATION IN THE NBAF AND NPBAF COMPLEXES, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17640523; DOI=10.1016/j.neuron.2007.06.019;
RA   Lessard J., Wu J.I., Ranish J.A., Wan M., Winslow M.M., Staahl B.T., Wu H.,
RA   Aebersold R., Graef I.A., Crabtree G.R.;
RT   "An essential switch in subunit composition of a chromatin remodeling
RT   complex during neural development.";
RL   Neuron 55:201-215(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-697, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365; SER-384; SER-697;
RP   SER-699; SER-703; SER-731; SER-765; SER-773 AND THR-1874, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-431 AND ARG-1277, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [9]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=22952240; DOI=10.1074/jbc.r111.309302;
RA   Euskirchen G., Auerbach R.K., Snyder M.;
RT   "SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse
RT   functions.";
RL   J. Biol. Chem. 287:30897-30905(2012).
RN   [10]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=26601204; DOI=10.1126/sciadv.1500447;
RA   Kadoch C., Crabtree G.R.;
RT   "Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic
RT   insights gained from human genomics.";
RL   Sci. Adv. 1:E1500447-E1500447(2015).
CC   -!- FUNCTION: Involved in transcriptional activation and repression of
CC       select genes by chromatin remodeling (alteration of DNA-nucleosome
CC       topology). Component of SWI/SNF chromatin remodeling complexes that
CC       carry out key enzymatic activities, changing chromatin structure by
CC       altering DNA-histone contacts within a nucleosome in an ATP-dependent
CC       manner. Binds DNA non-specifically (PubMed:22952240, PubMed:26601204).
CC       Belongs to the neural progenitors-specific chromatin remodeling complex
CC       (npBAF complex) and the neuron-specific chromatin remodeling complex
CC       (nBAF complex). During neural development a switch from a
CC       stem/progenitor to a postmitotic chromatin remodeling mechanism occurs
CC       as neurons exit the cell cycle and become committed to their adult
CC       state. The transition from proliferating neural stem/progenitor cells
CC       to postmitotic neurons requires a switch in subunit composition of the
CC       npBAF and nBAF complexes. As neural progenitors exit mitosis and
CC       differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A
CC       and PHF10/BAF45A, are exchanged for homologous alternative
CC       ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-
CC       specific complexes (nBAF). The npBAF complex is essential for the self-
CC       renewal/proliferative capacity of the multipotent neural stem cells.
CC       The nBAF complex along with CREST plays a role regulating the activity
CC       of genes essential for dendrite growth (PubMed:17640523).
CC       {ECO:0000250|UniProtKB:O14497, ECO:0000269|PubMed:17640523,
CC       ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.
CC   -!- SUBUNIT: Component of SWI/SNF chromatin remodeling complexes, in some
CC       of which it can be mutually exclusive with ARID1B/BAF250B. The
CC       canonical complex contains a catalytic subunit (either
CC       SMARCA4/BRG1/BAF190A or SMARCA2/BRM/BAF190B) and at least SMARCE1,
CC       ACTL6A/BAF53, SMARCC1/BAF155, SMARCC2/BAF170, and SMARCB1/SNF5/BAF47.
CC       Other subunits specific to each of the complexes may also be present
CC       permitting several possible combinations developmentally and tissue
CC       specific. Component of the BAF (SWI/SNF-A) complex, which includes at
CC       least actin (ACTB), ARID1A/BAF250A, ARID1B/BAF250B, SMARCA2/BRM,
CC       SMARCA4/BRG1/BAF190A, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57,
CC       SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C (By similarity). In
CC       muscle cells, the BAF complex also contains DPF3. Component of neural
CC       progenitors-specific chromatin remodeling complex (npBAF complex)
CC       composed of at least, ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A,
CC       SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A,
CC       SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170,
CC       PHF10/BAF45A, ACTL6A/BAF53A and actin. Component of neuron-specific
CC       chromatin remodeling complex (nBAF complex) composed of at least,
CC       ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C,
CC       SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47,
CC       SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, DPF1/BAF45B,
CC       DPF3/BAF45C, ACTL6B/BAF53B and actin (PubMed:17640523). Component of a
CC       SWI/SNF-like EBAFa complex, at least composed of SMARCA4/BRG1/BAF190A,
CC       SMARCB1/BAF47/SNF5, ACTL6A/BAF53A, SMARCE1/BAF57, SMARCD1/BAF60A,
CC       SMARCC1/BAF155, SMARCC2/BAF170, BAF250A and MLLT1/ENL. Interacts
CC       through its C-terminus with SMARCA2/BRM/BAF190B and
CC       SMARCA4/BRG1/BAF190A. Interacts with SMARCC1/BAF155 (By similarity).
CC       {ECO:0000250|UniProtKB:O14497, ECO:0000269|PubMed:17640523,
CC       ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.
CC   -!- INTERACTION:
CC       A2BH40; O35845: Smarca4; NbExp=2; IntAct=EBI-371499, EBI-371515;
CC       A2BH40; Q3TKT4: Smarca4; NbExp=7; IntAct=EBI-371499, EBI-1210244;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=A2BH40-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A2BH40-2; Sequence=VSP_038737, VSP_038739;
CC       Name=3;
CC         IsoId=A2BH40-3; Sequence=VSP_038740;
CC       Name=4;
CC         IsoId=A2BH40-4; Sequence=VSP_038737, VSP_038738, VSP_038739;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at high levels in the
CC       testis. {ECO:0000269|PubMed:11318604}.
CC   -!- DEVELOPMENTAL STAGE: Expressed ubiquitously throughout the developing
CC       spinal cord, brain and other embryonic tissues at 10.5 dpc-16.5 dpc. In
CC       the earlier stages at 9.5 dpc and 10.5 dpc, is fairly ubiquitous though
CC       with clearly elevated expression in the progress zone and lateral
CC       mesoderm of limb buds, optic and otic vesicle, neural tube, and brain.
CC       Later on at 11.5 dpc and 12.5 dpc, expression becomes more restricted
CC       and is confined to the interdigital area of limbs, dorsal
CC       mes/metencephalon, neocortex, and neural tube. Expression is seen in
CC       the eye lens from 10.5 dpc until 12.5 dpc.
CC       {ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:17640523}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF268912; AAK54504.1; -; mRNA.
DR   EMBL; BX537327; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR751606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR925752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC082554; AAH82554.1; -; mRNA.
DR   CCDS; CCDS38908.1; -. [A2BH40-1]
DR   CCDS; CCDS89836.1; -. [A2BH40-4]
DR   RefSeq; NP_001074288.1; NM_001080819.1. [A2BH40-1]
DR   RefSeq; XP_006539390.1; XM_006539327.3. [A2BH40-2]
DR   BMRB; A2BH40; -.
DR   SMR; A2BH40; -.
DR   BioGRID; 220298; 32.
DR   ComplexPortal; CPX-1232; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1233; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1236; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1237; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1240; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1241; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1244; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1245; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1251; Embryonic stem cell-specific SWI/SNF ATP-dependent chromatin remodeling complex.
DR   ComplexPortal; CPX-1252; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1253; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1256; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1257; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1261; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1262; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   DIP; DIP-58952N; -.
DR   IntAct; A2BH40; 22.
DR   MINT; A2BH40; -.
DR   STRING; 10090.ENSMUSP00000122354; -.
DR   GlyConnect; 2144; 1 N-Linked glycan (1 site).
DR   GlyGen; A2BH40; 1 site.
DR   iPTMnet; A2BH40; -.
DR   PhosphoSitePlus; A2BH40; -.
DR   SwissPalm; A2BH40; -.
DR   EPD; A2BH40; -.
DR   jPOST; A2BH40; -.
DR   MaxQB; A2BH40; -.
DR   PaxDb; A2BH40; -.
DR   PeptideAtlas; A2BH40; -.
DR   PRIDE; A2BH40; -.
DR   ProteomicsDB; 283266; -. [A2BH40-1]
DR   ProteomicsDB; 283267; -. [A2BH40-2]
DR   ProteomicsDB; 283268; -. [A2BH40-3]
DR   ProteomicsDB; 283269; -. [A2BH40-4]
DR   Antibodypedia; 1691; 221 antibodies.
DR   Ensembl; ENSMUST00000008024; ENSMUSP00000008024; ENSMUSG00000007880. [A2BH40-4]
DR   Ensembl; ENSMUST00000105897; ENSMUSP00000101517; ENSMUSG00000007880. [A2BH40-1]
DR   GeneID; 93760; -.
DR   KEGG; mmu:93760; -.
DR   UCSC; uc008vdh.1; mouse. [A2BH40-1]
DR   UCSC; uc008vdj.1; mouse. [A2BH40-4]
DR   CTD; 8289; -.
DR   MGI; MGI:1935147; Arid1a.
DR   eggNOG; KOG2510; Eukaryota.
DR   GeneTree; ENSGT00940000155194; -.
DR   HOGENOM; CLU_000974_1_1_1; -.
DR   InParanoid; A2BH40; -.
DR   OMA; PGEKQHE; -.
DR   OrthoDB; 256110at2759; -.
DR   PhylomeDB; A2BH40; -.
DR   Reactome; R-MMU-3214858; RMTs methylate histone arginines.
DR   Reactome; R-MMU-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   BioGRID-ORCS; 93760; 8 hits in 59 CRISPR screens.
DR   ChiTaRS; Arid1a; mouse.
DR   PRO; PR:A2BH40; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; A2BH40; protein.
DR   Bgee; ENSMUSG00000007880; Expressed in secondary oocyte and 339 other tissues.
DR   ExpressionAtlas; A2BH40; baseline and differential.
DR   Genevisible; A2BH40; MM.
DR   GO; GO:0035060; C:brahma complex; IEA:InterPro.
DR   GO; GO:0000785; C:chromatin; IDA:MGI.
DR   GO; GO:0071565; C:nBAF complex; IDA:UniProtKB.
DR   GO; GO:0071564; C:npBAF complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0016514; C:SWI/SNF complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; ISO:MGI.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:MGI.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043044; P:ATP-dependent chromatin remodeling; IDA:MGI.
DR   GO; GO:0003205; P:cardiac chamber development; IMP:MGI.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; IMP:MGI.
DR   GO; GO:0006325; P:chromatin organization; IPI:MGI.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:MGI.
DR   GO; GO:0007566; P:embryo implantation; IMP:MGI.
DR   GO; GO:0030900; P:forebrain development; IMP:MGI.
DR   GO; GO:0001704; P:formation of primary germ layer; IMP:MGI.
DR   GO; GO:0007369; P:gastrulation; IMP:MGI.
DR   GO; GO:0042921; P:glucocorticoid receptor signaling pathway; ISO:MGI.
DR   GO; GO:0070829; P:heterochromatin maintenance; IMP:MGI.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0001843; P:neural tube closure; IMP:MGI.
DR   GO; GO:0006337; P:nucleosome disassembly; ISO:MGI.
DR   GO; GO:0003408; P:optic cup formation involved in camera-type eye development; IMP:MGI.
DR   GO; GO:0060674; P:placenta blood vessel development; IMP:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0019827; P:stem cell population maintenance; IMP:MGI.
DR   GO; GO:1901998; P:toxin transport; IMP:MGI.
DR   Gene3D; 1.10.150.60; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR001606; ARID_dom.
DR   InterPro; IPR036431; ARID_dom_sf.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021906; BAF250/Osa.
DR   InterPro; IPR033388; BAF250_C.
DR   InterPro; IPR030094; BAF250a.
DR   PANTHER; PTHR12656; PTHR12656; 1.
DR   PANTHER; PTHR12656:SF12; PTHR12656:SF12; 1.
DR   Pfam; PF01388; ARID; 1.
DR   Pfam; PF12031; BAF250_C; 1.
DR   SMART; SM00501; BRIGHT; 1.
DR   SUPFAM; SSF46774; SSF46774; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51011; ARID; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromatin regulator; DNA-binding;
KW   Methylation; Neurogenesis; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   CHAIN           2..2283
FT                   /note="AT-rich interactive domain-containing protein 1A"
FT                   /id="PRO_0000391619"
FT   DOMAIN          1018..1109
FT                   /note="ARID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00355"
FT   MOTIF           296..300
FT                   /note="LXXLL"
FT   MOTIF           1369..1388
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOTIF           1710..1714
FT                   /note="LXXLL"
FT   MOTIF           1965..1969
FT                   /note="LXXLL"
FT   MOTIF           2083..2087
FT                   /note="LXXLL"
FT   COMPBIAS        16..20
FT                   /note="Poly-Pro"
FT   COMPBIAS        38..43
FT                   /note="Poly-Ala"
FT   COMPBIAS        53..425
FT                   /note="Gly-rich"
FT   COMPBIAS        331..350
FT                   /note="Ala-rich"
FT   COMPBIAS        405..612
FT                   /note="Gln-rich"
FT   COMPBIAS        999..1002
FT                   /note="Poly-Ser"
FT   COMPBIAS        1328..1500
FT                   /note="Gln-rich"
FT   COMPBIAS        1545..1644
FT                   /note="Pro-rich"
FT   COMPBIAS        1761..1766
FT                   /note="Poly-Glu"
FT   COMPBIAS        1773..1778
FT                   /note="Poly-Glu"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         234
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         287
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         431
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         697
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         699
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         703
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         731
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1277
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1613
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1874
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1886
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1903
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1927
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   MOD_RES         1942
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14497"
FT   VAR_SEQ         1..385
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11318604,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038737"
FT   VAR_SEQ         1181
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038738"
FT   VAR_SEQ         1336
FT                   /note="Q -> QQQQQR (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11318604,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038739"
FT   VAR_SEQ         1367..1583
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_038740"
FT   CONFLICT        697
FT                   /note="S -> F (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        750
FT                   /note="D -> E (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        758
FT                   /note="P -> S (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        833
FT                   /note="M -> I (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1011
FT                   /note="K -> Q (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1148
FT                   /note="P -> H (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1181..1182
FT                   /note="SR -> G (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1635
FT                   /note="M -> I (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1755
FT                   /note="Y -> S (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1795
FT                   /note="S -> P (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1799
FT                   /note="N -> S (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1929
FT                   /note="E -> D (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1956
FT                   /note="E -> D (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1974
FT                   /note="S -> P (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2233
FT                   /note="A -> P (in Ref. 1; AAK54504)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2283 AA;  242092 MW;  0F14BB1372CC4268 CRC64;
     MAAQVAPAAA SSLGNPPPPP SELKKAEQQQ REEAGGEAAA AAAERGEMKA AAGQESEGPA
     VGPPQPLGKE LQDGAESNGG GGGGGAGSGG GPGAEPDLKN SNGNAGPRPA LNNNLPEPPG
     GGGGGGSSSS DGVGAPPHSA AAALPPPAYG FGQAYGRSPS AVAAAAAAVF HQQHGGQQSP
     GLAALQSGGG GGLEPYAGPQ QNSHDHGFPN HQYNSYYPNR SAYPPPPQAY ALSSPRGGTP
     GSGAAAAAGS KPPPSSSASA SSSSSSFAQQ RFGAMGGGGP SAAGGGTPQP TATPTLNQLL
     TSPSSARGYQ GYPGGDYGGG PQDGGAGKGP ADMASQCWGA AAAAAAAAAA VSGGAQQRSH
     HAPMSPGSSG GGGQPLARTP QSSSPMDQMG KMRPQPYGGT NPYSQQQGPP SGPQQGHGYP
     GQPYGSQTPQ RYPMTMQGRA QSAMGSLSYA QQIPPYGQQG PSAYGQQGQT PYYNQQSPHP
     QQQPPYAQQP PSQTPHAQPS YQQQPQTQQP QLQSSQPPYS QQPSQPPHQQ SPTPYPSQQS
     TTQQHPQSQP PYSQPQAQSP YQQQQPQQPA SSSLSQQAAY PQPQPQQSQQ TAYSQQRFPP
     PQELSQDSFG SQASSAPSMT SSKGGQEDMN LSLQSRPSSL PDLSGSIDDL PMGTEGALSP
     GVSTSGISSS QGEQSNPAQS PFSPHTSPHL PGIRGPSPSP VGSPASVAQS RSGPLSPAAV
     PGNQMPPRPP SGQSDSIMHP SMNQSSIAQD RGYMQRNPQM PQYTSPQPGS ALSPRQPSGG
     QMHSGVGSYQ QNSMGSYGPQ GSQYGPQGGY PRQPNYNALP NANYPNAGMA GSMNPMGAGG
     QMHGQPGIPP YGTLPPGRMA HASMGNRPYG PNMANMPPQV GSGMCPPPGG MNRKTQESAV
     AMHVAANSIQ NRPPGYPNMN QGGMMGTGPP YGQGINSMAG MINPQGPPYP MGGTMANNSA
     GMAASPEMMG LGDVKLTPAT KMNNKADGTP KTESKSKKSS SSTTTNEKIT KLYELGGEPE
     RKMWVDRYLA FTEEKAMGMT NLPAVGRKPL DLYRLYVSVK EIGGLTQVNK NKKWRELATN
     LNVGTSSSAA SSLKKQYIQC LYAFECKIER GEDPPPDIFA AADSKKSQPK IQPPSPAGSG
     SMQGPQTPQS TSSSMAEGGD LKPPTPASTP HSQIPPLPGM SRSNSVGIQD AFPDGSDPTF
     QKRNSMTPNP GYQPSMNTSD MMGRMSYEPN KDPYGSMRKA PGSDPFMSSG QGPNGGMGDP
     YSRAAGPGLG SVAMGPRQHY PYGGPYDRVR TEPGIGPEGN MGTGAPQPNL MPSTPDSGMY
     SPSRYPPQQQ QQQQQQHDSY GNQFSTQGTP SSSPFPSQQT TMYQQQQQNY KRPMDGTYGP
     PAKRHEGEMY SVPYSAGQGQ PQQQQLPAAQ SQPASQPQAA QPSPQQDVYN QYSNAYPASA
     TAATDRRPAG GPQNQFPFQF GRDRVSAPPG SSAQQNMPPQ MMGGPIQASA EVAQQGTMWQ
     GRNDMTYNYA NRQNTGSATQ GPAYHGVNRT DEMLHTDQRA NHEGPWPSHG TRQPPYGPSA
     PVPPMTRPPP SNYQPPPSMP NHIPQVSSPA PLPRPMENRT SPSKSPFLHS GMKMQKAGPP
     VPASHIAPTP VQPPMIRRDI TFPPGSVEAT QPVLKQRRRL TMKDIGTPEA WRVMMSLKSG
     LLAESTWALD TINILLYDDN SIMTFNLSQL PGLLELLVEY FRRCLIEIFG ILKEYEVGDP
     GQRTLLDPGR FTKVYSPAHT EEEEEEHLDP KLEEEEEEGV GNDEEMAFLG KDKPSSENNE
     EKLVSKFDKL PVKIVQRNDP FVVDCSDKLG RVQEFDSGLL HWRIGGGDTT EHIQTHFESK
     IELLPSRPYV PCPTPPRKHL TTVEGTPGTT EQEGPPPDGL PEKRITATMD DMLSTRSSTL
     TDEGAKSAEA TKESSKFPFG ISPAQSHRNI KILEDEPHSK DETPLCTLLD WQDSLAKRCV
     CVSNTIRSLS FVPGNDFEMS KHPGLLLILG KLILLHHKHP ERKQAPLTYE KEEEQDQGVS
     CDKVEWWWDC LEMLRENTLV TLANISGQLD LSPYPESICL PVLDGLLHWA VCPSAEAQDP
     FSTLGPNAVL SPQRLVLETL SKLSIQDNNV DLILATPPFS RLEKLYSTMV RFLSDRKNPV
     CREMAVVLLA NLAQGDSLAA RAIAVQKGSI GNLLGFLEDS LAATQFQQSQ ASLLHMQNPP
     FEPTSVDMMR RAARALLALA KVDENHSEFT LYESRLLDIS VSPLMNSLVS QVICDVLFLI
     GQS
//
